¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
1/15 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2022-01-14
Á¶È¸¼ö
208


¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù. 

À̹ø¿¡ Á¦°¡ ¹ßÇ¥µå¸± ³í¹®ÀÇ Á¦¸ñÀº

"Antigen transfer from non-APCs to APCs impacts the efficacy and safety of protein- and mRNA- based vaccines"

À¸·Î Áö³­ÇØ 10¿ù¿¡ Nano today (IF: 19.49)¿¡ ¹ßÇ¥µÈ ³í¹®ÀÔ´Ï´Ù. 

mRNA ¹× protein ÇüÅÂÀÇ vaccineµéÀÌ ±×µ¿¾È È¿°úÀûÀÎ ¹æ¾î¸é¿ªÀ» À¯µµÇϱâ À§Çؼ­´Â APC¸¦ ¸Å°³ÇØ¾ß ÇϹǷΠAPC¸¦ Ÿ°ÙÇÏ·Á´Â ¿©·¯ ½ÃµµµéÀÌ ±×µ¿¾È ¸¹ÀÌ º¸°í°¡ µÇ¾ú°í, À̸¦ À§ÇÑ ´Ù¾çÇÑ ³ª³ë¹°ÁúµéÀÌ °í¾ÈµÇ¾ú½À´Ï´Ù. 

À̹ø ³í¹®¿¡¼­´Â APC¿¡ Á÷Á¢ Àü´ÞµÇ´Â °Í »Ó¸¸ ¾Æ´Ï¶ó, APC°¡ ¾Æ´Ñ ´Ù¾çÇÑ ÀÏ¹Ý ¼¼Æ÷(non-APC)·Î ºÎÅÍ APC¿¡ Àü´Þ µÇ´Â °ÍÀÌ ¹é½ÅÀÇ È¿°ú ¹× ¾ÈÀü¼º¿¡ ±â¿©ÇÑ´Ù´Â ºÎºÐÀ» ¹àÇû½À´Ï´Ù. 

ÀúÈñ´Â ´ëºÎºÐ ¸é¿ª¼¼Æ÷¿¡ ÃÊÁ¡À» µÎ°í ½ÇÇèÀ» ÇÏÁö¸¸, ÇØ´ç ³í¹®¿¡¼­ ¹àÈ÷°í Àִ ´Ù¸¥ ¿©·¯ ¼¼Æ÷µéÀÇ °ü¿©°¡ Æò¼Ò ¿¬±¸½Ç ³»¿¡¼­µµ Á¾Á¾ ³íÀÇ°¡ µÇ´ø ºÎºÐÀ̾úÀ¸¸ç, Èï¹Ì·Î¿î ÁÖÁ¦¶ó°í »ý°¢ µË´Ï´Ù. 

 

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù. 

 

ö±Õ ¿Ã¸².

³í¹®¸µÅ© : https://doi.org/10.1016/j.nantod.2021.101326

÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
1/22 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2021³â JACI(Journal of allerygy andclinicalimmunology)¿¡ ÃâÆÇµÈ " IL-10 production by ILC2s requires Blimp-1 and cMaf, modulates celllar metabolism, and ameliorates airway hyperreactivity" ÀÔ´Ï´Ù. ÀÌ ³í¹®¿¡¼­´ÂIL-10À» »ý¼ºÇÏ..
ÀÌÀü±Û
1/15 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä ³ª·¡ÀÔ´Ï´Ù. À̹øÁÖ Á¦°¡ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº 2021³â 9¿ù Science signaling¿¡ °ÔÀçµÈ "SIRPα sequesters SHP-2 to promote IL-4 and IL-13 signaling and the alternative activation of macrophages" ¶ó´Â Á¦¸ñÀÇ ³í¹®ÀÔ´Ï´Ù. º» ³í¹®Àº Macrophage°¡ M2a macrophage·Î alternative a..